ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
supersub
|
25K |
12M |
21 |
09/04/23 |
09/04/23 |
ASX - By Stock
|
25K
|
12M
|
21
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
supersub
|
25K |
12M |
5 |
17/03/23 |
17/03/23 |
ASX - By Stock
|
25K
|
12M
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Competitive landscape
|
|
supersub
|
244 |
115K |
18 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
244
|
115K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene VAXINIA trial advances to Combination Cohort
|
|
supersub
|
153 |
75K |
4 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
153
|
75K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
supersub
|
25K |
12M |
11 |
29/01/23 |
29/01/23 |
ASX - By Stock
|
25K
|
12M
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
supersub
|
25K |
12M |
4 |
21/01/23 |
21/01/23 |
ASX - By Stock
|
25K
|
12M
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC
|
|
supersub
|
77 |
47K |
7 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
77
|
47K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
|
|
supersub
|
299 |
104K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
299
|
104K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT
|
|
supersub
|
115 |
70K |
5 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
115
|
70K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT
|
|
supersub
|
115 |
70K |
19 |
28/05/22 |
28/05/22 |
ASX - By Stock
|
115
|
70K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
supersub
|
25K |
12M |
9 |
01/11/21 |
01/11/21 |
ASX - By Stock
|
25K
|
12M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Report to Shareholders
|
|
supersub
|
84 |
26K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
84
|
26K
|
4
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
supersub
|
33K |
16M |
2 |
16/09/21 |
16/09/21 |
Charts
|
33K
|
16M
|
2
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
supersub
|
33K |
16M |
0 |
15/09/21 |
15/09/21 |
Charts
|
33K
|
16M
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: S&P DJI Announces September 2021 Quarterly Rebalance
|
|
supersub
|
114 |
72K |
6 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
114
|
72K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: COVID ARDS Trial Topline 60-Day Results
|
|
supersub
|
1.6K |
464K |
3 |
08/07/21 |
08/07/21 |
ASX - By Stock
|
1.6K
|
464K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Novartis countdown
|
|
supersub
|
373 |
112K |
3 |
04/07/21 |
04/07/21 |
ASX - By Stock
|
373
|
112K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
supersub
|
340 |
113K |
1 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
113K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
supersub
|
10K |
3.0M |
5 |
26/06/21 |
26/06/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
supersub
|
17K |
6.7M |
1 |
22/06/21 |
22/06/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Integrity.....
|
|
supersub
|
190 |
41K |
11 |
19/06/21 |
19/06/21 |
ASX - By Stock
|
190
|
41K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
supersub
|
796 |
395K |
0 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
796
|
395K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
supersub
|
2.0K |
692K |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
692K
|
1
|
|